Prognostic Significance of Concurrent MYC, BCL2 and/or BCL6 Expression in Diffuse Large B-Cell Lymphoma

The Impact of Serum MicroRNA-21 on Outcome of Diffuse Large B-Cell Lymphoma Patients

CLINICOPATHOLOGICAL AND PROGNOSTIC SIGNIFICANCE OF PLATELET TO LYMPHOCYTE RATIO IN DIFFUSE LARGE B-CELL LYMPHOMA: A META-ANALYSIS

The significance of MUM1, BCL-6, and CD10 in identification of the cellular origin of head and neck diffuse large B-cell lymphomas. An immuno-histochemical study.

Relationship between C-MYC, BCL-2 and BCL-6 Genetic Abnormalities and Bone Marrow Biopsy in B-Non-Hodgkin Lymphoma

Inverse correlation of concurrent BCL2, and C MYC expressions and CD30 ‎positivity as regard the Prognostic significance in diffuse large B-cell ‎lymphoma

Prognostic value of CD10, BCL6 and MUM1 in diffuse large B-cell lymphoma

A Clinicopathological Analysis Of Primary Gastric Lymphoma

Clinicopathological features of relapsed diffuse large B-cell lymphoma: South Egypt Cancer Institute experience

Study of high mobility group box 1 protein level in patients with diffuse large b cell lymphoma